GW 7647
Tocris Bioscience | Catalog # 1677
Key Product Details
Description
Product Description
GW 7647 is a potent and highly selective PPARα agonist (EC50 values are 6, 1100 and 6200 nM for human PPARα, PPARγ and PPARδ receptors respectively). Modulates oleate metabolism and mitochondrial enzyme gene expression in mature myotubules in vitro. Has lipid-lowering effects following oral administration in vivo. Reduces NO production in macrophages; exhibits anti-inflammatory properties.Licensing Information
Sold for research purposes under agreement from GlaxoSmithKline
Product Specifications for GW 7647
Molecular Weight
Formula
Storage
Purity
Chemical Name
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 50.27 | 100 | |
| Ethanol | 12.57 | 25 |
Preparing Stock Solutions for GW 7647
The following data is based on the product molecular weight 502.75.
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.99 mL | 9.95 mL | 19.89 mL |
| 5 mM | 0.40 mL | 1.99 mL | 3.98 mL |
| 10 mM | 0.20 mL | 0.99 mL | 1.99 mL |
| 50 mM | 0.04 mL | 0.20 mL | 0.40 mL |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 47 publications citing the usage of this product.
- Paukkeri PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages. Br.J.Pharmacol. 2007 PMID: 17891158
- Cunard Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors. J.Immunol. 2002 PMID: 11884448
- Muoio Peroxisome proliferator-activated receptor-α regulates fatty acid utilization in primary human skeletal muscle cells. Diabetes 2002 PMID: 11916905
- Brown Identification of a subtype selective human PPARα agonist through parallel-array synthesis. Bioorg.Med.Chem.Lett. 2001 PMID: 11354382
Product Documents for GW 7647
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for GW 7647
For research use only
Related Research Areas
Citations for GW 7647
Customer Reviews for GW 7647 (1)
Have you used GW 7647?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
-
Species: MouseAssay Type: In VitroCell Line/Tissue: J774 murine macrophagesVerified Customer | Posted 12/07/2019GW7647 is the most potent PPARalpha agonist that reduces LPS-induced iNOS expression and NO production in macrophages by enhancing iNOS protein degradation through the proteasome pathway. Concentration 3, 10 and 30 uM showed dose-dependent inhibition.
There are no reviews that match your criteria.